Biotech Sell-Off Continues

enter site Biotech stocks followed the market down today with the NASDAQ being down 1.8% and the S&P down 1.5% . The biotech ETF’s tracked the market closely with the IBB down almost 2% and the XBI down 1.65%. The summer rally which gathered momentum with the acquisition of Medarex by Bristol on July 24 has given […]

Continue Reading 0

Caution on biotechs and energy

enter site Biotech stocks were unusually weak today with many mid-caps down 3-4%. High flier CBST was down even more due to an Oppenheimer downgrade. The ELN lawsuit against Biogen regarding the Tysabri deal with JNJ didn’t help matters. More analysis to follow as this is a travel day. Energy stocks were also on the weak side […]

Continue Reading 0

Weak dollar boosts Reflation Trade

where to buy modafinil uk forum Ten Month Low on the Dollar The US Dollar Index Future (DXY) gapped down 1.3% today at 78.27 approaching September 2008 lows. This dollar drop immediately brought money into gold up nearly 2% to the 950+ level. Gold is the pure play on the dollar. Gold and silver stocks also rallied with AUY,GDX, NEM and […]

Continue Reading 0

Medarex acquisition ignites broad biotech rally

Bristol Myers announced Thursday that they will buy Medarex (MEDX) for $16/share or $2.1B a 90% premium over yesterdays’ market price of $8.40. Medarex is one of the leading biotech companies focused in human antibody development for use in a broad range of therapeutic areas such as cancer, autoimmune diseases and infectious diseases.The companies already […]

Continue Reading 0

Rally Update:Energy and metals lead the way

As of this writing two hours before the Friday close crude was above $63 up 3%. Since this rally began last week energy stocks have moved up in lockstep. Better than expected housing starts today have boosted the energy complex with volatile nat gas stocks such as KWK and SWN the biggest winners. Another good […]

Continue Reading 0

Broad market move up 2%+; Reflation trade back

The reflation trade caught some bids today with energy, precious metal, real estate, agricultural and industrial stocks all following the lead of the financials.Many of the energy stocks are near their intermediate lows so this could be a good entry point for the longer term.As examples COP, KWK and SWN have all bounced off their […]

Continue Reading 0

Rayno 2009 Biotechnology Portfolio-Mid Year Update

The Rayno Biopharm Portfolio is flat YTD. This compares to the broad-based ETF IBB which also flat YTD and the XBI which is down 5% YTD. Biotech in 2009 has significantly lagged the NASDAQ which is up 11%, however the S&P 500 is down 2.7% YTD. The Rayno portfolio consists of 24 stocks weighted by […]

Continue Reading 1

Reflation Trade kicks back: stay cautious

The gloomy job report has risk traders seeking cash. * The Dow,S&P and Nasdaq were all down 2.6% +. * Money flowed into the Dollar and US Treasuries as investors were seeking safety. * Precious metal stocks were down 3%; gold was down 1.25%. * The energy sector was hard hit as oil sold off […]

Continue Reading 0

Reflation trade turns cautious: 3% Market Sell-Off

The market had a broadbase sell-off today with weakness in all sectors especially commodity stocks such as energy and materials. The 30% rally since March 9th has come to a screeching halt. A global growth warning from the World bank gave a bleak report cutting estimates for 2009 from a 1.7% contraction to 2.9% contraction. […]

Continue Reading 0

H1N1 Flu Pandemic is here but Moderate in Severity

Drug Stocks rally on Flu News On Thursday June 11,the WHO raised its alert on swine flu (H1N1) to the Phase 6 pandemic level calling further spread of the virus inevitable. The Director- General of WHO Dr. Margaret Chan said, “Globally we have good reason to believe that this pandemic, at least in its early […]

Continue Reading 0